News | August 10, 2023
Granules India posts Q1 FY24 revenue from operations at Rs. 985.5 Cr
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
The facility is over 79,000 square feet and is equipped with packaging lines
The audit is a pre-approval inspection for three products filed from the facility
Granules now have a total of 53 ANDA approvals from USFDA
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
The two overhead tanks commissioned at a cost of Rs 57 lakh will be maintained by the village panchayats.
This is the sixth successful USFDA audit for this facility
Granules India has reported consolidated financial results for the period ended December 31, 2021
Subscribe To Our Newsletter & Stay Updated
